Bank of America Corporation »

Karyopharm Therapeutics shares owned by Bank of America Corporation

Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by Bank of America Corporation from 13F filings

Historical chart of Bank of America Corporation investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by Bank of America Corporation

Quarter filed Position value Share count Share price at filing
2026-03-31 $109k 20k 5.57

More positions owned by Bank of America Corporation

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Broadcom (AVGO)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for Bank of America Corporation

Top funds holding Karyopharm Therapeutics

Ikarian Capital
Commodore Capital
RA Capital Management
Adage Capital Partners GP
T. Rowe Price Investment Management
Susquehanna International
Caption Management
Goldman Sachs Group
Catalio Capital Management
Boothbay Fund Management
Squadron Capital Management
Vanguard Capital Management
Jane Street
Vanguard Group
Millennium Management

View all funds holding Karyopharm Therapeutics